A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)

NCT01794000 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

341

Enrollment

INDUSTRY

Sponsor class

Stopped The study is being terminated for lack of efficacy.

Conditions

Sickle Cell Disease

Interventions

DRUG: Prasugrel
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]